Ellevest, Inc. Fate Therapeutics Inc Transaction History

Ellevest, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$17.78 - $42.39 $817 - $1,949	-46 Reduced 68.66%	21 $1,000
Q1 2022 Apr 19, 2022	BUY	$29.67 - $60.28 $1,987 - $4,038	67 New	67 $3,000
Q4 2021 Jan 24, 2022	SELL	$47.84 - $64.34 $1,243 - $1,672	-26 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$59.27 - $95.73 $1,541 - $2,488	26 New	26 $2,000

176

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $136M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.